Works matching IS 22113428 AND DT 2022 AND VI 45 AND IP 5

Results: 17

Correction to: YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma.

Published in:

2022

By:

Kuo, Yi-Zih;
Kang, Ya-Rong;
Chang, Wei-Lun;
Sim, Lydia Chin Ling;
Hsieh, Tzu-Chin;
Chang, Chu-Han;
Wang, Yi-Ching;
Tsai, Ching-Jung;
Huang, Li-Chun;
Tsai, Sen-Tien;
Wu, Li-Wha

Publication type:

Correction Notice

Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 5, p. 1019, doi. 10.1007/s13402-022-00707-3

By:

Xian, Linfeng;
Zhao, Pei;
Chen, Xi;
Wei, Zhimin;
Ji, Hongxiang;
Zhao, Jun;
Liu, Wenbin;
Li, Zishuai;
Liu, Donghong;
Han, Xue;
Qian, Youwen;
Dong, Hui;
Zhou, Xiong;
Fan, Junyan;
Zhu, Xiaoqiong;
Yin, Jianhua;
Tan, Xiaojie;
Jiang, Dongming;
Yu, Hongping;
Cao, Guangwen

Publication type:

Article

Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 5, p. 831, doi. 10.1007/s13402-022-00706-4

By:

Schcolnik-Cabrera, Alejandro;
Juárez-López, Daniel

Publication type:

Article

HDAC6: A unique HDAC family member as a cancer target.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 5, p. 779, doi. 10.1007/s13402-022-00704-6

By:

Kaur, Sumeet;
Rajoria, Prerna;
Chopra, Madhu

Publication type:

Article

Combination of RSK inhibitor LJH-685 and FLT3 inhibitor FF-10101 promoted apoptosis and proliferation inhibition of AML cell lines.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 5, p. 1005, doi. 10.1007/s13402-022-00703-7

By:

Zhang, Sen;
Liu, Jun;
Lu, Zi-Yi;
Xue, Yu-Tong;
Mu, Xing-Ru;
Liu, Yang;
Cao, Jiang;
Li, Zhen-Yu;
Li, Feng;
Xu, Kai-Lin;
Wu, Qing-Yun

Publication type:

Article

Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 5, p. 991, doi. 10.1007/s13402-022-00702-8

By:

Fischer-Mertens, Janina;
Otte, Felix;
Roderwieser, Andrea;
Rosswog, Carolina;
Kahlert, Yvonne;
Werr, Lisa;
Hellmann, Anna-Maria;
Berding, Maya;
Chiu, Bill;
Bartenhagen, Christoph;
Fischer, Matthias

Publication type:

Article

Nm23-H1 induces apoptosis in primary effusion lymphoma cells via inhibition of NF-κB signaling through interaction with oncogenic latent protein vFLIP K13 of Kaposi's sarcoma-associated herpes virus.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 5, p. 967, doi. 10.1007/s13402-022-00701-9

By:

Mohanty, Suchitra;
Kumar, Amit;
Das, Piyanki;
Sahu, Sushil Kumar;
Mukherjee, Ratnadeep;
Ramachandranpillai, Rajagopal;
Nair, Santhosh Sankaran;
Choudhuri, Tathagata

Publication type:

Article

Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 5, p. 755, doi. 10.1007/s13402-022-00700-w

By:

Bozorgi, Azam;
Bozorgi, Maryam;
Khazaei, Mozafar

Publication type:

Article

Proteasomal deubiquitylase activity enhances cell surface recycling of the epidermal growth factor receptor in non-small cell lung cancer.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 5, p. 951, doi. 10.1007/s13402-022-00699-0

By:

Wang, Shanshan;
Wang, Taishu;
Yang, Qianyi;
Cheng, Shaoxuan;
Liu, Fang;
Yang, Guoheng;
Wang, Fuqiang;
Wang, Ruilin;
Yang, Dian;
Zhou, Mingyu;
Duan, Chengen;
Zhang, Yingqiu;
Liu, Han;
Dai, Zhaoxia;
Tian, Kang;
Liu, Shuyan

Publication type:

Article

A comprehensive review of SHP2 and its role in cancer.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 5, p. 729, doi. 10.1007/s13402-022-00698-1

By:

Asmamaw, Moges Dessale;
Shi, Xiao-Jing;
Zhang, Li-Rong;
Liu, Hong-Min

Publication type:

Article

A m<sup>6</sup>A methyltransferase-mediated immune signature determines prognosis, immune landscape and immunotherapy efficacy in patients with lung adenocarcinoma.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 5, p. 931, doi. 10.1007/s13402-022-00697-2

By:

Lei, Mengyuan;
Luo, Chenghan;
Zhang, Jiayang;
Cao, Wenjun;
Ge, Jian;
Zhao, Min

Publication type:

Article

Activation of the HSP27-AKT axis contributes to gefitinib resistance in non-small cell lung cancer cells independent of EGFR mutations.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 5, p. 913, doi. 10.1007/s13402-022-00696-3

By:

Choi, Seul-Ki;
Kim, Minsuh;
Lee, Haeseung;
Kwon, Youngjoo;
Cha, Hyuk-Jin;
Jang, Se Jin;
Na, Younghwa;
Lee, Yun-Sil

Publication type:

Article

YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 5, p. 893, doi. 10.1007/s13402-022-00695-4

By:

Kuo, Yi-Zih;
Kang, Ya-Rong;
Chang, Wei-Lun;
Sim, Lydia Chin-Ling;
Hsieh, Tzu-Chin;
Chang, Chu-Han;
Wang, Yi-Ching;
Tsai, Ching-Jung;
Huang, Li-Chun;
Tsai, Sen-Tien;
Wu, Li-Wha

Publication type:

Article

Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 5, p. 709, doi. 10.1007/s13402-022-00694-5

By:

Gu, Jia;
Zhu, Neng;
Li, Hong-Fang;
Zhao, Tan-Jun;
Zhang, Chan-Juan;
Liao, Duan-Fang;
Qin, Li

Publication type:

Article

Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 5, p. 873, doi. 10.1007/s13402-022-00693-6

By:

Dey, Pranay;
Joshi, Mansi;
Mujawar, Aaiyas;
Malhotra, Renu;
De, Abhijit

Publication type:

Article

Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin β1/FAK signaling pathway.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 5, p. 861, doi. 10.1007/s13402-022-00687-4

By:

Song, Yunfeng;
Ye, Lei;
Tan, Yuan;
Tong, Huan;
Lv, Zeheng;
Wan, Xiaoping;
Li, Yiran

Publication type:

Article

Correction to: CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer.

Published in:

2022

By:

Zhou, Zhenyu;
Peng, Yaorong;
Wu, Xiaoying;
Meng, Shiyu;
Yu, Wei;
Zhao, Jinghua;
Zhang, Heyun;
Wang, Jie;
Li, Wenbin

Publication type:

Correction Notice